Biotechnology

Enzolytics, Inc.

Enzolytics Inc. Reports Q1 2025 Zero Sales and Net Loss of $92,239

Enzolytics Inc. Reports Zero Sales, Net Loss Decreases to $394,188 in 2024

PicoCELA

Santech

Highway

Trinity Biotech

Euda Health

Aimei Health Tech

Sable Offshore

Pomdoctor

Ascent Solar Tech

A SPAC III Acquisition

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap